SOAT1 and familial pancreatic carcinoma: Inhibition of cholesterol esterification by treatment with the SOAT1 inhibitor avasimibe reduces pancreatic cancer cell proliferation in vitro and in vivo, mechanistically suggesting that avasimibe enhances ER stress and apoptosis in pancreatic cancer cells [56].